Global Next Generation Cancer Diagnostics Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Next Generation Cancer Diagnostics Market Size was estimated at USD 2243.19 million in 2023 and is projected to reach USD 6211.22 million by 2029, exhibiting a CAGR of 18.50% during the forecast period.
This report provides a deep insight into the global Next Generation Cancer Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Next Generation Cancer Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Next Generation Cancer Diagnostics market in any manner.
Global Next Generation Cancer Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Market Segmentation (by Type)
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Next Generation Cancer Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Next Generation Cancer Diagnostics Market Size was estimated at USD 2243.19 million in 2023 and is projected to reach USD 6211.22 million by 2029, exhibiting a CAGR of 18.50% during the forecast period.
This report provides a deep insight into the global Next Generation Cancer Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Next Generation Cancer Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Next Generation Cancer Diagnostics market in any manner.
Global Next Generation Cancer Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Market Segmentation (by Type)
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Next Generation Cancer Diagnostics Market
- Overview of the regional outlook of the Next Generation Cancer Diagnostics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Next Generation Cancer Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Next Generation Cancer Diagnostics
1.2 Key Market Segments
1.2.1 Next Generation Cancer Diagnostics Segment by Type
1.2.2 Next Generation Cancer Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEXT GENERATION CANCER DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Next Generation Cancer Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Next Generation Cancer Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEXT GENERATION CANCER DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Next Generation Cancer Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Next Generation Cancer Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Next Generation Cancer Diagnostics Sales Sites, Area Served, Product Type
3.6 Next Generation Cancer Diagnostics Market Competitive Situation and Trends
3.6.1 Next Generation Cancer Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Next Generation Cancer Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEXT GENERATION CANCER DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Next Generation Cancer Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEXT GENERATION CANCER DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEXT GENERATION CANCER DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Next Generation Cancer Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Next Generation Cancer Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Next Generation Cancer Diagnostics Price by Type (2019-2024)
7 NEXT GENERATION CANCER DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Next Generation Cancer Diagnostics Market Sales by Application (2019-2024)
7.3 Global Next Generation Cancer Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Next Generation Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
8 NEXT GENERATION CANCER DIAGNOSTICS MARKET SEGMENTATION BY REGION
8.1 Global Next Generation Cancer Diagnostics Sales by Region
8.1.1 Global Next Generation Cancer Diagnostics Sales by Region
8.1.2 Global Next Generation Cancer Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Next Generation Cancer Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Next Generation Cancer Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Next Generation Cancer Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Next Generation Cancer Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Next Generation Cancer Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Cepheid
9.1.1 Cepheid Next Generation Cancer Diagnostics Basic Information
9.1.2 Cepheid Next Generation Cancer Diagnostics Product Overview
9.1.3 Cepheid Next Generation Cancer Diagnostics Product Market Performance
9.1.4 Cepheid Business Overview
9.1.5 Cepheid Next Generation Cancer Diagnostics SWOT Analysis
9.1.6 Cepheid Recent Developments
9.2 Koninklijke Philips N.V
9.2.1 Koninklijke Philips N.V Next Generation Cancer Diagnostics Basic Information
9.2.2 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Overview
9.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Market Performance
9.2.4 Koninklijke Philips N.V Business Overview
9.2.5 Koninklijke Philips N.V Next Generation Cancer Diagnostics SWOT Analysis
9.2.6 Koninklijke Philips N.V Recent Developments
9.3 F. Hoffmann-La Roche Ltd
9.3.1 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Basic Information
9.3.2 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Overview
9.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Market Performance
9.3.4 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics SWOT Analysis
9.3.5 F. Hoffmann-La Roche Ltd Business Overview
9.3.6 F. Hoffmann-La Roche Ltd Recent Developments
9.4 Qiagen
9.4.1 Qiagen Next Generation Cancer Diagnostics Basic Information
9.4.2 Qiagen Next Generation Cancer Diagnostics Product Overview
9.4.3 Qiagen Next Generation Cancer Diagnostics Product Market Performance
9.4.4 Qiagen Business Overview
9.4.5 Qiagen Recent Developments
9.5 Novartis AG
9.5.1 Novartis AG Next Generation Cancer Diagnostics Basic Information
9.5.2 Novartis AG Next Generation Cancer Diagnostics Product Overview
9.5.3 Novartis AG Next Generation Cancer Diagnostics Product Market Performance
9.5.4 Novartis AG Business Overview
9.5.5 Novartis AG Recent Developments
9.6 Abbott
9.6.1 Abbott Next Generation Cancer Diagnostics Basic Information
9.6.2 Abbott Next Generation Cancer Diagnostics Product Overview
9.6.3 Abbott Next Generation Cancer Diagnostics Product Market Performance
9.6.4 Abbott Business Overview
9.6.5 Abbott Recent Developments
9.7 Thermo Fisher Scientific
9.7.1 Thermo Fisher Scientific Next Generation Cancer Diagnostics Basic Information
9.7.2 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Overview
9.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Market Performance
9.7.4 Thermo Fisher Scientific Business Overview
9.7.5 Thermo Fisher Scientific Recent Developments
9.8 Opko Health
9.8.1 Opko Health Next Generation Cancer Diagnostics Basic Information
9.8.2 Opko Health Next Generation Cancer Diagnostics Product Overview
9.8.3 Opko Health Next Generation Cancer Diagnostics Product Market Performance
9.8.4 Opko Health Business Overview
9.8.5 Opko Health Recent Developments
9.9 Myriad Genetics
9.9.1 Myriad Genetics Next Generation Cancer Diagnostics Basic Information
9.9.2 Myriad Genetics Next Generation Cancer Diagnostics Product Overview
9.9.3 Myriad Genetics Next Generation Cancer Diagnostics Product Market Performance
9.9.4 Myriad Genetics Business Overview
9.9.5 Myriad Genetics Recent Developments
9.10 Agilent Technologies
9.10.1 Agilent Technologies Next Generation Cancer Diagnostics Basic Information
9.10.2 Agilent Technologies Next Generation Cancer Diagnostics Product Overview
9.10.3 Agilent Technologies Next Generation Cancer Diagnostics Product Market Performance
9.10.4 Agilent Technologies Business Overview
9.10.5 Agilent Technologies Recent Developments
9.11 GE Healthcare
9.11.1 GE Healthcare Next Generation Cancer Diagnostics Basic Information
9.11.2 GE Healthcare Next Generation Cancer Diagnostics Product Overview
9.11.3 GE Healthcare Next Generation Cancer Diagnostics Product Market Performance
9.11.4 GE Healthcare Business Overview
9.11.5 GE Healthcare Recent Developments
9.12 PerkinElmer
9.12.1 PerkinElmer Next Generation Cancer Diagnostics Basic Information
9.12.2 PerkinElmer Next Generation Cancer Diagnostics Product Overview
9.12.3 PerkinElmer Next Generation Cancer Diagnostics Product Market Performance
9.12.4 PerkinElmer Business Overview
9.12.5 PerkinElmer Recent Developments
9.13 Genomic Health
9.13.1 Genomic Health Next Generation Cancer Diagnostics Basic Information
9.13.2 Genomic Health Next Generation Cancer Diagnostics Product Overview
9.13.3 Genomic Health Next Generation Cancer Diagnostics Product Market Performance
9.13.4 Genomic Health Business Overview
9.13.5 Genomic Health Recent Developments
9.14 Illumina
9.14.1 Illumina Next Generation Cancer Diagnostics Basic Information
9.14.2 Illumina Next Generation Cancer Diagnostics Product Overview
9.14.3 Illumina Next Generation Cancer Diagnostics Product Market Performance
9.14.4 Illumina Business Overview
9.14.5 Illumina Recent Developments
9.15 Hologic
9.15.1 Hologic Next Generation Cancer Diagnostics Basic Information
9.15.2 Hologic Next Generation Cancer Diagnostics Product Overview
9.15.3 Hologic Next Generation Cancer Diagnostics Product Market Performance
9.15.4 Hologic Business Overview
9.15.5 Hologic Recent Developments
9.16 Almac Group
9.16.1 Almac Group Next Generation Cancer Diagnostics Basic Information
9.16.2 Almac Group Next Generation Cancer Diagnostics Product Overview
9.16.3 Almac Group Next Generation Cancer Diagnostics Product Market Performance
9.16.4 Almac Group Business Overview
9.16.5 Almac Group Recent Developments
9.17 Janssen Global Services
9.17.1 Janssen Global Services Next Generation Cancer Diagnostics Basic Information
9.17.2 Janssen Global Services Next Generation Cancer Diagnostics Product Overview
9.17.3 Janssen Global Services Next Generation Cancer Diagnostics Product Market Performance
9.17.4 Janssen Global Services Business Overview
9.17.5 Janssen Global Services Recent Developments
9.18 Sysmex Corporation
9.18.1 Sysmex Corporation Next Generation Cancer Diagnostics Basic Information
9.18.2 Sysmex Corporation Next Generation Cancer Diagnostics Product Overview
9.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Product Market Performance
9.18.4 Sysmex Corporation Business Overview
9.18.5 Sysmex Corporation Recent Developments
10 NEXT GENERATION CANCER DIAGNOSTICS MARKET FORECAST BY REGION
10.1 Global Next Generation Cancer Diagnostics Market Size Forecast
10.2 Global Next Generation Cancer Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Next Generation Cancer Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Next Generation Cancer Diagnostics Market Size Forecast by Region
10.2.4 South America Next Generation Cancer Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Next Generation Cancer Diagnostics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Next Generation Cancer Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Next Generation Cancer Diagnostics by Type (2025-2030)
11.1.2 Global Next Generation Cancer Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Next Generation Cancer Diagnostics by Type (2025-2030)
11.2 Global Next Generation Cancer Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global Next Generation Cancer Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global Next Generation Cancer Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Next Generation Cancer Diagnostics
1.2 Key Market Segments
1.2.1 Next Generation Cancer Diagnostics Segment by Type
1.2.2 Next Generation Cancer Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEXT GENERATION CANCER DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Next Generation Cancer Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Next Generation Cancer Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEXT GENERATION CANCER DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Next Generation Cancer Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Next Generation Cancer Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Next Generation Cancer Diagnostics Sales Sites, Area Served, Product Type
3.6 Next Generation Cancer Diagnostics Market Competitive Situation and Trends
3.6.1 Next Generation Cancer Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Next Generation Cancer Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEXT GENERATION CANCER DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Next Generation Cancer Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEXT GENERATION CANCER DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEXT GENERATION CANCER DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Next Generation Cancer Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Next Generation Cancer Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Next Generation Cancer Diagnostics Price by Type (2019-2024)
7 NEXT GENERATION CANCER DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Next Generation Cancer Diagnostics Market Sales by Application (2019-2024)
7.3 Global Next Generation Cancer Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Next Generation Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
8 NEXT GENERATION CANCER DIAGNOSTICS MARKET SEGMENTATION BY REGION
8.1 Global Next Generation Cancer Diagnostics Sales by Region
8.1.1 Global Next Generation Cancer Diagnostics Sales by Region
8.1.2 Global Next Generation Cancer Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Next Generation Cancer Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Next Generation Cancer Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Next Generation Cancer Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Next Generation Cancer Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Next Generation Cancer Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Cepheid
9.1.1 Cepheid Next Generation Cancer Diagnostics Basic Information
9.1.2 Cepheid Next Generation Cancer Diagnostics Product Overview
9.1.3 Cepheid Next Generation Cancer Diagnostics Product Market Performance
9.1.4 Cepheid Business Overview
9.1.5 Cepheid Next Generation Cancer Diagnostics SWOT Analysis
9.1.6 Cepheid Recent Developments
9.2 Koninklijke Philips N.V
9.2.1 Koninklijke Philips N.V Next Generation Cancer Diagnostics Basic Information
9.2.2 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Overview
9.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Market Performance
9.2.4 Koninklijke Philips N.V Business Overview
9.2.5 Koninklijke Philips N.V Next Generation Cancer Diagnostics SWOT Analysis
9.2.6 Koninklijke Philips N.V Recent Developments
9.3 F. Hoffmann-La Roche Ltd
9.3.1 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Basic Information
9.3.2 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Overview
9.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Market Performance
9.3.4 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics SWOT Analysis
9.3.5 F. Hoffmann-La Roche Ltd Business Overview
9.3.6 F. Hoffmann-La Roche Ltd Recent Developments
9.4 Qiagen
9.4.1 Qiagen Next Generation Cancer Diagnostics Basic Information
9.4.2 Qiagen Next Generation Cancer Diagnostics Product Overview
9.4.3 Qiagen Next Generation Cancer Diagnostics Product Market Performance
9.4.4 Qiagen Business Overview
9.4.5 Qiagen Recent Developments
9.5 Novartis AG
9.5.1 Novartis AG Next Generation Cancer Diagnostics Basic Information
9.5.2 Novartis AG Next Generation Cancer Diagnostics Product Overview
9.5.3 Novartis AG Next Generation Cancer Diagnostics Product Market Performance
9.5.4 Novartis AG Business Overview
9.5.5 Novartis AG Recent Developments
9.6 Abbott
9.6.1 Abbott Next Generation Cancer Diagnostics Basic Information
9.6.2 Abbott Next Generation Cancer Diagnostics Product Overview
9.6.3 Abbott Next Generation Cancer Diagnostics Product Market Performance
9.6.4 Abbott Business Overview
9.6.5 Abbott Recent Developments
9.7 Thermo Fisher Scientific
9.7.1 Thermo Fisher Scientific Next Generation Cancer Diagnostics Basic Information
9.7.2 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Overview
9.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Market Performance
9.7.4 Thermo Fisher Scientific Business Overview
9.7.5 Thermo Fisher Scientific Recent Developments
9.8 Opko Health
9.8.1 Opko Health Next Generation Cancer Diagnostics Basic Information
9.8.2 Opko Health Next Generation Cancer Diagnostics Product Overview
9.8.3 Opko Health Next Generation Cancer Diagnostics Product Market Performance
9.8.4 Opko Health Business Overview
9.8.5 Opko Health Recent Developments
9.9 Myriad Genetics
9.9.1 Myriad Genetics Next Generation Cancer Diagnostics Basic Information
9.9.2 Myriad Genetics Next Generation Cancer Diagnostics Product Overview
9.9.3 Myriad Genetics Next Generation Cancer Diagnostics Product Market Performance
9.9.4 Myriad Genetics Business Overview
9.9.5 Myriad Genetics Recent Developments
9.10 Agilent Technologies
9.10.1 Agilent Technologies Next Generation Cancer Diagnostics Basic Information
9.10.2 Agilent Technologies Next Generation Cancer Diagnostics Product Overview
9.10.3 Agilent Technologies Next Generation Cancer Diagnostics Product Market Performance
9.10.4 Agilent Technologies Business Overview
9.10.5 Agilent Technologies Recent Developments
9.11 GE Healthcare
9.11.1 GE Healthcare Next Generation Cancer Diagnostics Basic Information
9.11.2 GE Healthcare Next Generation Cancer Diagnostics Product Overview
9.11.3 GE Healthcare Next Generation Cancer Diagnostics Product Market Performance
9.11.4 GE Healthcare Business Overview
9.11.5 GE Healthcare Recent Developments
9.12 PerkinElmer
9.12.1 PerkinElmer Next Generation Cancer Diagnostics Basic Information
9.12.2 PerkinElmer Next Generation Cancer Diagnostics Product Overview
9.12.3 PerkinElmer Next Generation Cancer Diagnostics Product Market Performance
9.12.4 PerkinElmer Business Overview
9.12.5 PerkinElmer Recent Developments
9.13 Genomic Health
9.13.1 Genomic Health Next Generation Cancer Diagnostics Basic Information
9.13.2 Genomic Health Next Generation Cancer Diagnostics Product Overview
9.13.3 Genomic Health Next Generation Cancer Diagnostics Product Market Performance
9.13.4 Genomic Health Business Overview
9.13.5 Genomic Health Recent Developments
9.14 Illumina
9.14.1 Illumina Next Generation Cancer Diagnostics Basic Information
9.14.2 Illumina Next Generation Cancer Diagnostics Product Overview
9.14.3 Illumina Next Generation Cancer Diagnostics Product Market Performance
9.14.4 Illumina Business Overview
9.14.5 Illumina Recent Developments
9.15 Hologic
9.15.1 Hologic Next Generation Cancer Diagnostics Basic Information
9.15.2 Hologic Next Generation Cancer Diagnostics Product Overview
9.15.3 Hologic Next Generation Cancer Diagnostics Product Market Performance
9.15.4 Hologic Business Overview
9.15.5 Hologic Recent Developments
9.16 Almac Group
9.16.1 Almac Group Next Generation Cancer Diagnostics Basic Information
9.16.2 Almac Group Next Generation Cancer Diagnostics Product Overview
9.16.3 Almac Group Next Generation Cancer Diagnostics Product Market Performance
9.16.4 Almac Group Business Overview
9.16.5 Almac Group Recent Developments
9.17 Janssen Global Services
9.17.1 Janssen Global Services Next Generation Cancer Diagnostics Basic Information
9.17.2 Janssen Global Services Next Generation Cancer Diagnostics Product Overview
9.17.3 Janssen Global Services Next Generation Cancer Diagnostics Product Market Performance
9.17.4 Janssen Global Services Business Overview
9.17.5 Janssen Global Services Recent Developments
9.18 Sysmex Corporation
9.18.1 Sysmex Corporation Next Generation Cancer Diagnostics Basic Information
9.18.2 Sysmex Corporation Next Generation Cancer Diagnostics Product Overview
9.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Product Market Performance
9.18.4 Sysmex Corporation Business Overview
9.18.5 Sysmex Corporation Recent Developments
10 NEXT GENERATION CANCER DIAGNOSTICS MARKET FORECAST BY REGION
10.1 Global Next Generation Cancer Diagnostics Market Size Forecast
10.2 Global Next Generation Cancer Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Next Generation Cancer Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Next Generation Cancer Diagnostics Market Size Forecast by Region
10.2.4 South America Next Generation Cancer Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Next Generation Cancer Diagnostics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Next Generation Cancer Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Next Generation Cancer Diagnostics by Type (2025-2030)
11.1.2 Global Next Generation Cancer Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Next Generation Cancer Diagnostics by Type (2025-2030)
11.2 Global Next Generation Cancer Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global Next Generation Cancer Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global Next Generation Cancer Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Next Generation Cancer Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Next Generation Cancer Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Next Generation Cancer Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Next Generation Cancer Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Next Generation Cancer Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Diagnostics as of 2022)
Table 10. Global Market Next Generation Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Next Generation Cancer Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Next Generation Cancer Diagnostics Product Type
Table 13. Global Next Generation Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Next Generation Cancer Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Next Generation Cancer Diagnostics Market Challenges
Table 22. Global Next Generation Cancer Diagnostics Sales by Type (K Units)
Table 23. Global Next Generation Cancer Diagnostics Market Size by Type (M USD)
Table 24. Global Next Generation Cancer Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global Next Generation Cancer Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global Next Generation Cancer Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global Next Generation Cancer Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global Next Generation Cancer Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Next Generation Cancer Diagnostics Sales (K Units) by Application
Table 30. Global Next Generation Cancer Diagnostics Market Size by Application
Table 31. Global Next Generation Cancer Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global Next Generation Cancer Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global Next Generation Cancer Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global Next Generation Cancer Diagnostics Market Share by Application (2019-2024)
Table 35. Global Next Generation Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global Next Generation Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global Next Generation Cancer Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America Next Generation Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Next Generation Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Next Generation Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America Next Generation Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Next Generation Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Cepheid Next Generation Cancer Diagnostics Basic Information
Table 44. Cepheid Next Generation Cancer Diagnostics Product Overview
Table 45. Cepheid Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Cepheid Business Overview
Table 47. Cepheid Next Generation Cancer Diagnostics SWOT Analysis
Table 48. Cepheid Recent Developments
Table 49. Koninklijke Philips N.V Next Generation Cancer Diagnostics Basic Information
Table 50. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Overview
Table 51. Koninklijke Philips N.V Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Koninklijke Philips N.V Business Overview
Table 53. Koninklijke Philips N.V Next Generation Cancer Diagnostics SWOT Analysis
Table 54. Koninklijke Philips N.V Recent Developments
Table 55. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Basic Information
Table 56. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Overview
Table 57. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics SWOT Analysis
Table 59. F. Hoffmann-La Roche Ltd Business Overview
Table 60. F. Hoffmann-La Roche Ltd Recent Developments
Table 61. Qiagen Next Generation Cancer Diagnostics Basic Information
Table 62. Qiagen Next Generation Cancer Diagnostics Product Overview
Table 63. Qiagen Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Qiagen Business Overview
Table 65. Qiagen Recent Developments
Table 66. Novartis AG Next Generation Cancer Diagnostics Basic Information
Table 67. Novartis AG Next Generation Cancer Diagnostics Product Overview
Table 68. Novartis AG Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Recent Developments
Table 71. Abbott Next Generation Cancer Diagnostics Basic Information
Table 72. Abbott Next Generation Cancer Diagnostics Product Overview
Table 73. Abbott Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Abbott Business Overview
Table 75. Abbott Recent Developments
Table 76. Thermo Fisher Scientific Next Generation Cancer Diagnostics Basic Information
Table 77. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Overview
Table 78. Thermo Fisher Scientific Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Thermo Fisher Scientific Business Overview
Table 80. Thermo Fisher Scientific Recent Developments
Table 81. Opko Health Next Generation Cancer Diagnostics Basic Information
Table 82. Opko Health Next Generation Cancer Diagnostics Product Overview
Table 83. Opko Health Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Opko Health Business Overview
Table 85. Opko Health Recent Developments
Table 86. Myriad Genetics Next Generation Cancer Diagnostics Basic Information
Table 87. Myriad Genetics Next Generation Cancer Diagnostics Product Overview
Table 88. Myriad Genetics Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Myriad Genetics Business Overview
Table 90. Myriad Genetics Recent Developments
Table 91. Agilent Technologies Next Generation Cancer Diagnostics Basic Information
Table 92. Agilent Technologies Next Generation Cancer Diagnostics Product Overview
Table 93. Agilent Technologies Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Agilent Technologies Business Overview
Table 95. Agilent Technologies Recent Developments
Table 96. GE Healthcare Next Generation Cancer Diagnostics Basic Information
Table 97. GE Healthcare Next Generation Cancer Diagnostics Product Overview
Table 98. GE Healthcare Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. GE Healthcare Business Overview
Table 100. GE Healthcare Recent Developments
Table 101. PerkinElmer Next Generation Cancer Diagnostics Basic Information
Table 102. PerkinElmer Next Generation Cancer Diagnostics Product Overview
Table 103. PerkinElmer Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. PerkinElmer Business Overview
Table 105. PerkinElmer Recent Developments
Table 106. Genomic Health Next Generation Cancer Diagnostics Basic Information
Table 107. Genomic Health Next Generation Cancer Diagnostics Product Overview
Table 108. Genomic Health Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Genomic Health Business Overview
Table 110. Genomic Health Recent Developments
Table 111. Illumina Next Generation Cancer Diagnostics Basic Information
Table 112. Illumina Next Generation Cancer Diagnostics Product Overview
Table 113. Illumina Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Illumina Business Overview
Table 115. Illumina Recent Developments
Table 116. Hologic Next Generation Cancer Diagnostics Basic Information
Table 117. Hologic Next Generation Cancer Diagnostics Product Overview
Table 118. Hologic Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Hologic Business Overview
Table 120. Hologic Recent Developments
Table 121. Almac Group Next Generation Cancer Diagnostics Basic Information
Table 122. Almac Group Next Generation Cancer Diagnostics Product Overview
Table 123. Almac Group Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Almac Group Business Overview
Table 125. Almac Group Recent Developments
Table 126. Janssen Global Services Next Generation Cancer Diagnostics Basic Information
Table 127. Janssen Global Services Next Generation Cancer Diagnostics Product Overview
Table 128. Janssen Global Services Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Janssen Global Services Business Overview
Table 130. Janssen Global Services Recent Developments
Table 131. Sysmex Corporation Next Generation Cancer Diagnostics Basic Information
Table 132. Sysmex Corporation Next Generation Cancer Diagnostics Product Overview
Table 133. Sysmex Corporation Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Sysmex Corporation Business Overview
Table 135. Sysmex Corporation Recent Developments
Table 136. Global Next Generation Cancer Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 137. Global Next Generation Cancer Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Next Generation Cancer Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 139. North America Next Generation Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Next Generation Cancer Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 141. Europe Next Generation Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Next Generation Cancer Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 143. Asia Pacific Next Generation Cancer Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Next Generation Cancer Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 145. South America Next Generation Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Next Generation Cancer Diagnostics Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Next Generation Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Next Generation Cancer Diagnostics Sales Forecast by Type (2025-2030) & (K Units)
Table 149. Global Next Generation Cancer Diagnostics Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Next Generation Cancer Diagnostics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 151. Global Next Generation Cancer Diagnostics Sales (K Units) Forecast by Application (2025-2030)
Table 152. Global Next Generation Cancer Diagnostics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Next Generation Cancer Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Next Generation Cancer Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Next Generation Cancer Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Next Generation Cancer Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Next Generation Cancer Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Diagnostics as of 2022)
Table 10. Global Market Next Generation Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Next Generation Cancer Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Next Generation Cancer Diagnostics Product Type
Table 13. Global Next Generation Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Next Generation Cancer Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Next Generation Cancer Diagnostics Market Challenges
Table 22. Global Next Generation Cancer Diagnostics Sales by Type (K Units)
Table 23. Global Next Generation Cancer Diagnostics Market Size by Type (M USD)
Table 24. Global Next Generation Cancer Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global Next Generation Cancer Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global Next Generation Cancer Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global Next Generation Cancer Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global Next Generation Cancer Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Next Generation Cancer Diagnostics Sales (K Units) by Application
Table 30. Global Next Generation Cancer Diagnostics Market Size by Application
Table 31. Global Next Generation Cancer Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global Next Generation Cancer Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global Next Generation Cancer Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global Next Generation Cancer Diagnostics Market Share by Application (2019-2024)
Table 35. Global Next Generation Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global Next Generation Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global Next Generation Cancer Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America Next Generation Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Next Generation Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Next Generation Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America Next Generation Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Next Generation Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Cepheid Next Generation Cancer Diagnostics Basic Information
Table 44. Cepheid Next Generation Cancer Diagnostics Product Overview
Table 45. Cepheid Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Cepheid Business Overview
Table 47. Cepheid Next Generation Cancer Diagnostics SWOT Analysis
Table 48. Cepheid Recent Developments
Table 49. Koninklijke Philips N.V Next Generation Cancer Diagnostics Basic Information
Table 50. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Overview
Table 51. Koninklijke Philips N.V Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Koninklijke Philips N.V Business Overview
Table 53. Koninklijke Philips N.V Next Generation Cancer Diagnostics SWOT Analysis
Table 54. Koninklijke Philips N.V Recent Developments
Table 55. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Basic Information
Table 56. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Overview
Table 57. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics SWOT Analysis
Table 59. F. Hoffmann-La Roche Ltd Business Overview
Table 60. F. Hoffmann-La Roche Ltd Recent Developments
Table 61. Qiagen Next Generation Cancer Diagnostics Basic Information
Table 62. Qiagen Next Generation Cancer Diagnostics Product Overview
Table 63. Qiagen Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Qiagen Business Overview
Table 65. Qiagen Recent Developments
Table 66. Novartis AG Next Generation Cancer Diagnostics Basic Information
Table 67. Novartis AG Next Generation Cancer Diagnostics Product Overview
Table 68. Novartis AG Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Recent Developments
Table 71. Abbott Next Generation Cancer Diagnostics Basic Information
Table 72. Abbott Next Generation Cancer Diagnostics Product Overview
Table 73. Abbott Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Abbott Business Overview
Table 75. Abbott Recent Developments
Table 76. Thermo Fisher Scientific Next Generation Cancer Diagnostics Basic Information
Table 77. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Overview
Table 78. Thermo Fisher Scientific Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Thermo Fisher Scientific Business Overview
Table 80. Thermo Fisher Scientific Recent Developments
Table 81. Opko Health Next Generation Cancer Diagnostics Basic Information
Table 82. Opko Health Next Generation Cancer Diagnostics Product Overview
Table 83. Opko Health Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Opko Health Business Overview
Table 85. Opko Health Recent Developments
Table 86. Myriad Genetics Next Generation Cancer Diagnostics Basic Information
Table 87. Myriad Genetics Next Generation Cancer Diagnostics Product Overview
Table 88. Myriad Genetics Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Myriad Genetics Business Overview
Table 90. Myriad Genetics Recent Developments
Table 91. Agilent Technologies Next Generation Cancer Diagnostics Basic Information
Table 92. Agilent Technologies Next Generation Cancer Diagnostics Product Overview
Table 93. Agilent Technologies Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Agilent Technologies Business Overview
Table 95. Agilent Technologies Recent Developments
Table 96. GE Healthcare Next Generation Cancer Diagnostics Basic Information
Table 97. GE Healthcare Next Generation Cancer Diagnostics Product Overview
Table 98. GE Healthcare Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. GE Healthcare Business Overview
Table 100. GE Healthcare Recent Developments
Table 101. PerkinElmer Next Generation Cancer Diagnostics Basic Information
Table 102. PerkinElmer Next Generation Cancer Diagnostics Product Overview
Table 103. PerkinElmer Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. PerkinElmer Business Overview
Table 105. PerkinElmer Recent Developments
Table 106. Genomic Health Next Generation Cancer Diagnostics Basic Information
Table 107. Genomic Health Next Generation Cancer Diagnostics Product Overview
Table 108. Genomic Health Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Genomic Health Business Overview
Table 110. Genomic Health Recent Developments
Table 111. Illumina Next Generation Cancer Diagnostics Basic Information
Table 112. Illumina Next Generation Cancer Diagnostics Product Overview
Table 113. Illumina Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Illumina Business Overview
Table 115. Illumina Recent Developments
Table 116. Hologic Next Generation Cancer Diagnostics Basic Information
Table 117. Hologic Next Generation Cancer Diagnostics Product Overview
Table 118. Hologic Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Hologic Business Overview
Table 120. Hologic Recent Developments
Table 121. Almac Group Next Generation Cancer Diagnostics Basic Information
Table 122. Almac Group Next Generation Cancer Diagnostics Product Overview
Table 123. Almac Group Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Almac Group Business Overview
Table 125. Almac Group Recent Developments
Table 126. Janssen Global Services Next Generation Cancer Diagnostics Basic Information
Table 127. Janssen Global Services Next Generation Cancer Diagnostics Product Overview
Table 128. Janssen Global Services Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Janssen Global Services Business Overview
Table 130. Janssen Global Services Recent Developments
Table 131. Sysmex Corporation Next Generation Cancer Diagnostics Basic Information
Table 132. Sysmex Corporation Next Generation Cancer Diagnostics Product Overview
Table 133. Sysmex Corporation Next Generation Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Sysmex Corporation Business Overview
Table 135. Sysmex Corporation Recent Developments
Table 136. Global Next Generation Cancer Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 137. Global Next Generation Cancer Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Next Generation Cancer Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 139. North America Next Generation Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Next Generation Cancer Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 141. Europe Next Generation Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Next Generation Cancer Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 143. Asia Pacific Next Generation Cancer Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Next Generation Cancer Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 145. South America Next Generation Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Next Generation Cancer Diagnostics Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Next Generation Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Next Generation Cancer Diagnostics Sales Forecast by Type (2025-2030) & (K Units)
Table 149. Global Next Generation Cancer Diagnostics Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Next Generation Cancer Diagnostics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 151. Global Next Generation Cancer Diagnostics Sales (K Units) Forecast by Application (2025-2030)
Table 152. Global Next Generation Cancer Diagnostics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Next Generation Cancer Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Next Generation Cancer Diagnostics Market Size (M USD), 2019-2030
Figure 5. Global Next Generation Cancer Diagnostics Market Size (M USD) (2019-2030)
Figure 6. Global Next Generation Cancer Diagnostics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Next Generation Cancer Diagnostics Market Size by Country (M USD)
Figure 11. Next Generation Cancer Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Next Generation Cancer Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Next Generation Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Next Generation Cancer Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Next Generation Cancer Diagnostics Market Share by Type
Figure 18. Sales Market Share of Next Generation Cancer Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of Next Generation Cancer Diagnostics by Type in 2023
Figure 20. Market Size Share of Next Generation Cancer Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of Next Generation Cancer Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Next Generation Cancer Diagnostics Market Share by Application
Figure 24. Global Next Generation Cancer Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global Next Generation Cancer Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Next Generation Cancer Diagnostics Market Share by Application (2019-2024)
Figure 27. Global Next Generation Cancer Diagnostics Market Share by Application in 2023
Figure 28. Global Next Generation Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Next Generation Cancer Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Next Generation Cancer Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Next Generation Cancer Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Next Generation Cancer Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Next Generation Cancer Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Next Generation Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Next Generation Cancer Diagnostics Sales Market Share by Region in 2023
Figure 44. China Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Next Generation Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Next Generation Cancer Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Next Generation Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Next Generation Cancer Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Next Generation Cancer Diagnostics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Next Generation Cancer Diagnostics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Next Generation Cancer Diagnostics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Next Generation Cancer Diagnostics Market Share Forecast by Type (2025-2030)
Figure 65. Global Next Generation Cancer Diagnostics Sales Forecast by Application (2025-2030)
Figure 66. Global Next Generation Cancer Diagnostics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Next Generation Cancer Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Next Generation Cancer Diagnostics Market Size (M USD), 2019-2030
Figure 5. Global Next Generation Cancer Diagnostics Market Size (M USD) (2019-2030)
Figure 6. Global Next Generation Cancer Diagnostics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Next Generation Cancer Diagnostics Market Size by Country (M USD)
Figure 11. Next Generation Cancer Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Next Generation Cancer Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Next Generation Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Next Generation Cancer Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Next Generation Cancer Diagnostics Market Share by Type
Figure 18. Sales Market Share of Next Generation Cancer Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of Next Generation Cancer Diagnostics by Type in 2023
Figure 20. Market Size Share of Next Generation Cancer Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of Next Generation Cancer Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Next Generation Cancer Diagnostics Market Share by Application
Figure 24. Global Next Generation Cancer Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global Next Generation Cancer Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Next Generation Cancer Diagnostics Market Share by Application (2019-2024)
Figure 27. Global Next Generation Cancer Diagnostics Market Share by Application in 2023
Figure 28. Global Next Generation Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Next Generation Cancer Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Next Generation Cancer Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Next Generation Cancer Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Next Generation Cancer Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Next Generation Cancer Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Next Generation Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Next Generation Cancer Diagnostics Sales Market Share by Region in 2023
Figure 44. China Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Next Generation Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Next Generation Cancer Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Next Generation Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Next Generation Cancer Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Next Generation Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Next Generation Cancer Diagnostics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Next Generation Cancer Diagnostics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Next Generation Cancer Diagnostics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Next Generation Cancer Diagnostics Market Share Forecast by Type (2025-2030)
Figure 65. Global Next Generation Cancer Diagnostics Sales Forecast by Application (2025-2030)
Figure 66. Global Next Generation Cancer Diagnostics Market Share Forecast by Application (2025-2030)
